INTERNATIONAL PATENT: ROSWELL PARK CANCER INSTITUTE CORPORATION FILES APPLICATION FOR "PERCUTANEOUS SERIAL SAMPLING PORT FOR BIOLOGIC INVESTIGATIONS AND THERAPIES"

GENEVA, Feb. 4 -- ROSWELL PARK CANCER INSTITUTE CORPORATION (Elm and Carlton StreetsBuffalo, NY 14263) filed a patent application (PCT/US2025/039551) for "PERCUTANEOUS SERIAL SAMPLING PORT FOR BIOLOGIC INVESTIGATIONS AND THERAPIES" on Jul 28, 2025. With publication no. WO/2026/025116, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DEMMY, Todd, L. (555 N. Forest RoadWilliamsville, NY 14221)

Abstract: A device, system, and method are provided for accessing and sampling target tissues in body cavities. In some embodiments,...